Literature DB >> 24194573

Lipocalin 2 induces the epithelial-mesenchymal transition in stressed endometrial epithelial cells: possible correlation with endometriosis development in a mouse model.

Chi-Jr Liao1, Pei-Tzu Li, Ying-Chu Lee, Sheng-Hsiang Li, Sin Tak Chu.   

Abstract

Lipocalin 2 (LCN2) is an induced stressor that promotes the epithelial-mesenchymal transition (EMT). We previously demonstrated that the development of endometriosis in mice correlates with the secretion of LCN2 in the uterus. Here, we sought to clarify the relationship between LCN2 and EMT in endometrial epithelial cells and to determine whether LCN2 plays a role in endometriosis. Antibodies that functionally inhibit LCN2 slowed the growth of ectopic endometrial tissue in a mouse model of endometriosis, suggesting that LCN2 promotes the formation of endometriotic lesions. Using nutrient deprivation as a stressor, LCN2 expression was induced in cultured primary endometrial epithelial cells. As LCN2 levels increased, the cells transitioned from a round to a spindle-like morphology and dispersed. Immunochemical analyses revealed decreased levels of cytokeratin and increased levels of fibronectin in these endometrial cells, adhesive changes that correlate with induction of cell migration and invasion. Lcn2 knockdown also indicated that LCN2 promotes EMT and migration of endometrial epithelial cells. Our results suggest that stressful cellular microenvironments cause uterine tissues to secrete LCN2 and that this results in EMT of endometrial epithelial cells, which may correlate with the development of ectopic endometriosis. These findings shed light on the role of LCN2 in the pathology of endometrial disorders.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24194573     DOI: 10.1530/REP-13-0236

Source DB:  PubMed          Journal:  Reproduction        ISSN: 1470-1626            Impact factor:   3.906


  7 in total

1.  Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis.

Authors:  Qi Zhang; Peixin Dong; Xishi Liu; Noriaki Sakuragi; Sun-Wei Guo
Journal:  Sci Rep       Date:  2017-07-28       Impact factor: 4.379

Review 2.  Endometriosis in the Mouse: Challenges and Progress Toward a 'Best Fit' Murine Model.

Authors:  Katherine A Burns; Amelia M Pearson; Jessica L Slack; Elaine D Por; Alicia N Scribner; Nazmin A Eti; Richard O Burney
Journal:  Front Physiol       Date:  2022-01-13       Impact factor: 4.566

3.  Lipocalin-2 negatively regulates epithelial-mesenchymal transition through matrix metalloprotease-2 downregulation in gastric cancer.

Authors:  Sadaaki Nishimura; Yurie Yamamoto; Atsushi Sugimoto; Shuhei Kushiyama; Shingo Togano; Kenji Kuroda; Tomohisa Okuno; Hiroaki Kasashima; Masaichi Ohira; Kiyoshi Maeda; Masakazu Yashiro
Journal:  Gastric Cancer       Date:  2022-06-15       Impact factor: 7.701

4.  Spatial transcriptomics analysis of uterine gene expression in enhancer of zeste homolog 2 conditional knockout mice†.

Authors:  Ana M Mesa; Jiude Mao; Theresa I Medrano; Nathan J Bivens; Alexander Jurkevich; Geetu Tuteja; Paul S Cooke; Cheryl S Rosenfeld
Journal:  Biol Reprod       Date:  2021-11-15       Impact factor: 4.161

5.  Tranylcypromine, a lysine-specific demethylase 1 (LSD1) inhibitor, suppresses lesion growth and improves generalized hyperalgesia in mouse with induced endometriosis.

Authors:  Qunyan Sun; Ding Ding; Xishi Liu; Sun-Wei Guo
Journal:  Reprod Biol Endocrinol       Date:  2016-04-09       Impact factor: 5.211

Review 6.  Epithelial-to-Mesenchymal Transition in the Female Reproductive Tract: From Normal Functioning to Disease Pathology.

Authors:  Olena Bilyk; Mackenzie Coatham; Michael Jewer; Lynne-Marie Postovit
Journal:  Front Oncol       Date:  2017-07-05       Impact factor: 6.244

7.  The Lipocalin2 Gene is Regulated in Mammary Epithelial Cells by NFκB and C/EBP In Response to Mycoplasma.

Authors:  Wei Zhao; Lee Bendickson; Marit Nilsen-Hamilton
Journal:  Sci Rep       Date:  2020-05-06       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.